Showing results (471-480 of 586) with videos related to

Sort By:
Pageof 59
ESMO Open|June 24, 2024
A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumorsM A Gouda, J Shunyakova, A Naing, et al.
Clinical and Translational Science|February 10, 2026
An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid TumorsJatinder Kaur Mukker, Timothy A Yap, Anthony W Tolcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2023
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing CancersTimothy P DiPeri, Kurt W Evans, Maria Gabriela Raso, et al.
Journal of Cardiothoracic Surgery|January 1, 2015
A retrospective analysis of myocardial preservation techniques during coronary artery bypass graft surgery: are we protecting the heart?Luciano Candilio, Abdul Malik, Con Ariti, et al.
JCO Precision Oncology|February 2, 2022
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced CancersBenjamin Garmezy, Jinesh Gheeya, Heather Y Lin, et al.
Oncogene|July 26, 2023
A HUWE1 defect causes PARP inhibitor resistance by modulating the BRCA1-∆11q splice variantStephen J Pettitt, Nan Shao, Diana Zatreanu, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
ARID1A deficiency unleashes centromeric RNA transcription to drive chromosomal instability and boosts PKMYT1 inhibitor efficacy via RNA sensingChengguo Li, Xueqian Cheng, Weizhen Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2017
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type TumorsKurt W Evans, Erkan Yuca, Argun Akcakanat, et al.
Journal of the American Chemical Society|August 17, 2017
Carbodicarbenes: Unexpected π-Accepting Ability during Reactivity with Small MoleculesWen-Ching Chen, Wei-Chih Shih, Titel Jurca, et al.
Investigational New Drugs|September 24, 2021
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory studyRony Dev, Linda L Zhong, Abdulrazzak Zarifa, et al.
Pageof 59